US6309669B1
(en)
|
1984-03-16 |
2001-10-30 |
The United States Of America As Represented By The Secretary Of The Army |
Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix
|
USRE40786E1
(en)
|
1984-03-16 |
2009-06-23 |
The United States Of America As Represented By The Secretary Of The Army |
Vaccines against intracellular pathogens using antigens encapsulated within biodegradable-biocompatible microspheres
|
US5693343A
(en)
|
1984-03-16 |
1997-12-02 |
The United States Of America As Represented By The Secretary Of The Army |
Microparticle carriers of maximal uptake capacity by both M cells and non-M cells
|
US5417986A
(en)
*
|
1984-03-16 |
1995-05-23 |
The United States Of America As Represented By The Secretary Of The Army |
Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
|
US6410056B1
(en)
|
1984-03-16 |
2002-06-25 |
The United States Of America As Represented By The Secretary Of The Army |
Chemotherapeutic treatment of bacterial infections with an antibiotic encapsulated within a biodegradable polymeric matrix
|
US5762965A
(en)
*
|
1984-03-16 |
1998-06-09 |
The United States Of America As Represented By The Secretary Of The Army |
Vaccines against intracellular pathogens using antigens encapsulated within biodegradble-biocompatible microspheres
|
US20030161889A1
(en)
*
|
1984-03-16 |
2003-08-28 |
Reid Robert H. |
Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
|
US6217911B1
(en)
|
1995-05-22 |
2001-04-17 |
The United States Of America As Represented By The Secretary Of The Army |
sustained release non-steroidal, anti-inflammatory and lidocaine PLGA microspheres
|
GB2209937B
(en)
*
|
1987-09-21 |
1991-07-03 |
Depiopharm S A |
Water insoluble polypeptides
|
US5271945A
(en)
*
|
1988-07-05 |
1993-12-21 |
Takeda Chemical Industries, Ltd. |
Sustained release microcapsule for water soluble drug
|
US6323307B1
(en)
|
1988-08-08 |
2001-11-27 |
Cargill Dow Polymers, Llc |
Degradation control of environmentally degradable disposable materials
|
US5444113A
(en)
*
|
1988-08-08 |
1995-08-22 |
Ecopol, Llc |
End use applications of biodegradable polymers
|
US4990336A
(en)
*
|
1989-02-08 |
1991-02-05 |
Biosearch, Inc. |
Sustained release dosage form
|
EP0471036B2
(de)
*
|
1989-05-04 |
2004-06-23 |
Southern Research Institute |
Einkapselungsverfahren
|
US5439688A
(en)
*
|
1989-07-28 |
1995-08-08 |
Debio Recherche Pharmaceutique S.A. |
Process for preparing a pharmaceutical composition
|
US5225205A
(en)
*
|
1989-07-28 |
1993-07-06 |
Debiopharm S.A. |
Pharmaceutical composition in the form of microparticles
|
CH679207A5
(de)
*
|
1989-07-28 |
1992-01-15 |
Debiopharm Sa |
|
MY107937A
(en)
*
|
1990-02-13 |
1996-06-29 |
Takeda Chemical Industries Ltd |
Prolonged release microcapsules.
|
US5238714A
(en)
*
|
1990-10-02 |
1993-08-24 |
Board Of Regents, The University Of Texas System |
Efficient microcapsule preparation and method of use
|
US5484584A
(en)
*
|
1990-10-02 |
1996-01-16 |
Board Of Regents, The University Of Texas System |
Therapeutic and diagnostic use of modified polymeric microcapsules
|
US5102402A
(en)
|
1991-01-04 |
1992-04-07 |
Medtronic, Inc. |
Releasable coatings on balloon catheters
|
US5153002A
(en)
*
|
1991-03-04 |
1992-10-06 |
University Of Montreal |
Biocompatible gradient controlled release implant
|
AU8303691A
(en)
|
1991-04-24 |
1992-12-21 |
United States Of America, As Represented By The Secretary Of The Army, The |
Oral-intestinal vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
|
CH683149A5
(fr)
*
|
1991-07-22 |
1994-01-31 |
Debio Rech Pharma Sa |
Procédé pour la préparation de microsphères en matériau polymère biodégradable.
|
US5470582A
(en)
*
|
1992-02-07 |
1995-11-28 |
Syntex (U.S.A.) Inc. |
Controlled delivery of pharmaceuticals from preformed porous polymeric microparticles
|
US5876452A
(en)
*
|
1992-02-14 |
1999-03-02 |
Board Of Regents, University Of Texas System |
Biodegradable implant
|
US6013853A
(en)
*
|
1992-02-14 |
2000-01-11 |
The University Of Texas System |
Continuous release polymeric implant carrier
|
DE69311538D1
(de)
*
|
1992-03-12 |
1997-07-17 |
Alkermes Inc |
Acth enthaltende mikrokugeln mit gesteuerter abgabe
|
US5912015A
(en)
|
1992-03-12 |
1999-06-15 |
Alkermes Controlled Therapeutics, Inc. |
Modulated release from biocompatible polymers
|
US5571166A
(en)
*
|
1992-03-19 |
1996-11-05 |
Medtronic, Inc. |
Method of making an intraluminal stent
|
US5599352A
(en)
*
|
1992-03-19 |
1997-02-04 |
Medtronic, Inc. |
Method of making a drug eluting stent
|
US5510077A
(en)
*
|
1992-03-19 |
1996-04-23 |
Dinh; Thomas Q. |
Method of making an intraluminal stent
|
US5591224A
(en)
*
|
1992-03-19 |
1997-01-07 |
Medtronic, Inc. |
Bioelastomeric stent
|
US6514533B1
(en)
|
1992-06-11 |
2003-02-04 |
Alkermas Controlled Therapeutics, Inc. |
Device for the sustained release of aggregation-stabilized, biologically active agent
|
US5711968A
(en)
|
1994-07-25 |
1998-01-27 |
Alkermes Controlled Therapeutics, Inc. |
Composition and method for the controlled release of metal cation-stabilized interferon
|
US20030035845A1
(en)
*
|
1992-06-11 |
2003-02-20 |
Zale Stephen E. |
Composition for sustained release of non-aggregated erythropoietin
|
US5674534A
(en)
*
|
1992-06-11 |
1997-10-07 |
Alkermes, Inc. |
Composition for sustained release of non-aggregated erythropoietin
|
US5716644A
(en)
*
|
1992-06-11 |
1998-02-10 |
Alkermes, Inc. |
Composition for sustained release of non-aggregated erythropoietin
|
FR2693905B1
(fr)
*
|
1992-07-27 |
1994-09-02 |
Rhone Merieux |
Procédé de préparation de microsphères pour la libération prolongée de l'hormone LHRH et ses analogues, microsphères et formulations obtenues.
|
AU4932493A
(en)
*
|
1992-09-25 |
1994-04-26 |
Dynagen, Inc. |
An immunobooster for delayed release of immunogen
|
DK0674506T3
(da)
*
|
1992-12-02 |
2001-01-08 |
Alkermes Inc |
Væksthormonholdige mikrosfærer med styret frigivelse
|
UA61046C2
(en)
*
|
1992-12-07 |
2003-11-17 |
Takeda Chemical Industries Ltd |
Sustained-release preparation and method for its manufacture
|
TW333456B
(en)
*
|
1992-12-07 |
1998-06-11 |
Takeda Pharm Ind Co Ltd |
A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
WO1994021289A1
(en)
*
|
1993-03-22 |
1994-09-29 |
THE UNITED STATES OF AMERICA, as represented by THE SECRERATY OF THE ARMY |
Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
|
US5456917A
(en)
*
|
1993-04-12 |
1995-10-10 |
Cambridge Scientific, Inc. |
Method for making a bioerodible material for the sustained release of a medicament and the material made from the method
|
US6939546B2
(en)
|
1993-05-21 |
2005-09-06 |
The United States Of America As Represented By The Secretary Of The Army |
Model for testing immunogenicity of peptides
|
US5603960A
(en)
*
|
1993-05-25 |
1997-02-18 |
O'hagan; Derek T. |
Preparation of microparticles and method of immunization
|
US5643605A
(en)
*
|
1993-10-25 |
1997-07-01 |
Genentech, Inc. |
Methods and compositions for microencapsulation of adjuvants
|
US6913767B1
(en)
|
1993-10-25 |
2005-07-05 |
Genentech, Inc. |
Compositions for microencapsulation of antigens for use as vaccines
|
US6080429A
(en)
*
|
1993-10-25 |
2000-06-27 |
Genentech, Inc. |
Method for drying microspheres
|
ES2236700T3
(es)
*
|
1993-11-19 |
2005-07-16 |
Janssen Pharmaceutica N.V. |
1,2-benzazoles microencapsulados.
|
CA2190121A1
(en)
*
|
1994-03-15 |
1995-09-21 |
Edith Mathiowitz |
Polymeric gene delivery system
|
BR9507313A
(pt)
*
|
1994-04-08 |
1997-10-07 |
Atrix Lab Inc |
Composição liquida de liberação adequada para a formação de um implante de liberação controlada sistema polimérico curativo filmico microporoso biodegradável precursor de implante de liberação controlada para a implantação em um indivíduo polímero termoplástico solvente orgánico composicão de pré-polimero liquido componente de liberação controlada agente ativo uso da composição liquida de liberação e processos para forma um implante microporoso de liberação prolongada e para liberar um agente ativo em um individuo
|
US6013268A
(en)
|
1994-04-22 |
2000-01-11 |
Corixa Corporation |
Methods for enhancement of protective immune responses
|
US5876735A
(en)
*
|
1994-04-22 |
1999-03-02 |
Corixa Corporation |
Methods for enhancement of protective immune responses
|
US6855331B2
(en)
|
1994-05-16 |
2005-02-15 |
The United States Of America As Represented By The Secretary Of The Army |
Sustained release hydrophobic bioactive PLGA microspheres
|
US6447796B1
(en)
|
1994-05-16 |
2002-09-10 |
The United States Of America As Represented By The Secretary Of The Army |
Sustained release hydrophobic bioactive PLGA microspheres
|
US5583114A
(en)
|
1994-07-27 |
1996-12-10 |
Minnesota Mining And Manufacturing Company |
Adhesive sealant composition
|
USRE38827E1
(en)
|
1994-07-27 |
2005-10-11 |
3M Innovative Properties Company |
Adhesive sealant composition
|
KR100201352B1
(ko)
*
|
1995-03-16 |
1999-06-15 |
성재갑 |
단일주사 백신 제형
|
US6902743B1
(en)
|
1995-05-22 |
2005-06-07 |
The United States Of America As Represented By The Secretary Of The Army |
Therapeutic treatment and prevention of infections with a bioactive material(s) encapuslated within a biodegradable-bio-compatable polymeric matrix
|
US7033608B1
(en)
|
1995-05-22 |
2006-04-25 |
The United States Of America As Represented By The Secretary Of The Army |
“Burst-free” sustained release poly-(lactide/glycolide) microspheres
|
AUPN366795A0
(en)
*
|
1995-06-20 |
1995-07-13 |
Peptide Technology Limited |
Formulation for preventing reproductive function
|
EP0850051A2
(de)
*
|
1995-08-31 |
1998-07-01 |
Alkermes Controlled Therapeutics, Inc. |
Mittel zur verzögerten freisetzung eines wirkstoffs
|
US6265389B1
(en)
|
1995-08-31 |
2001-07-24 |
Alkermes Controlled Therapeutics, Inc. |
Microencapsulation and sustained release of oligonucleotides
|
IL123506A
(en)
|
1995-09-01 |
2004-12-15 |
Corixa Corp |
Polypeptide compounds and preparations for immunotherapy and diagnosis of tuberculosis
|
US6592877B1
(en)
*
|
1995-09-01 |
2003-07-15 |
Corixa Corporation |
Compounds and methods for immunotherapy and diagnosis of tuberculosis
|
US6458366B1
(en)
|
1995-09-01 |
2002-10-01 |
Corixa Corporation |
Compounds and methods for diagnosis of tuberculosis
|
US6290969B1
(en)
*
|
1995-09-01 |
2001-09-18 |
Corixa Corporation |
Compounds and methods for immunotherapy and diagnosis of tuberculosis
|
TW448055B
(en)
*
|
1995-09-04 |
2001-08-01 |
Takeda Chemical Industries Ltd |
Method of production of sustained-release preparation
|
US5942253A
(en)
*
|
1995-10-12 |
1999-08-24 |
Immunex Corporation |
Prolonged release of GM-CSF
|
US6270795B1
(en)
|
1995-11-09 |
2001-08-07 |
Microbiological Research Authority |
Method of making microencapsulated DNA for vaccination and gene therapy
|
JP2000500744A
(ja)
|
1995-11-09 |
2000-01-25 |
マイクロバイオロジカル リサーチ オーソリティー |
ワクチン接種および遺伝子治療のためのマイクロカプセル化dna
|
DE19545257A1
(de)
|
1995-11-24 |
1997-06-19 |
Schering Ag |
Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln
|
CA2192773C
(en)
|
1995-12-15 |
2008-09-23 |
Hiroaki Okada |
Production of sustained-release preparation for injection
|
CN1216636C
(zh)
*
|
1996-08-30 |
2005-08-31 |
派普泰克有限公司 |
肽缓释组合物
|
US5968895A
(en)
*
|
1996-12-11 |
1999-10-19 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
US20070185032A1
(en)
*
|
1996-12-11 |
2007-08-09 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
US6203813B1
(en)
|
1997-01-13 |
2001-03-20 |
Lance L. Gooberman |
Pharmaceutical delivery device and method of preparation therefor
|
US20020182258A1
(en)
*
|
1997-01-22 |
2002-12-05 |
Zycos Inc., A Delaware Corporation |
Microparticles for delivery of nucleic acid
|
US6126919A
(en)
*
|
1997-02-07 |
2000-10-03 |
3M Innovative Properties Company |
Biocompatible compounds for pharmaceutical drug delivery systems
|
WO1998035045A2
(en)
|
1997-02-12 |
1998-08-13 |
Corixa Corporation |
Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
|
US6261562B1
(en)
|
1997-02-25 |
2001-07-17 |
Corixa Corporation |
Compounds for immunotherapy of prostate cancer and methods for their use
|
ZA982968B
(en)
|
1997-04-09 |
1998-10-27 |
Corixa Corp |
Compositions and methods for the treatment and diagnosis of breast cancer
|
TW577759B
(en)
*
|
1997-04-18 |
2004-03-01 |
Ipsen Pharma Biotech |
Sustained release compositions in the form of microcapsules or implants and the process for their preparation
|
AU2010699A
(en)
|
1997-12-24 |
1999-07-19 |
Corixa Corporation |
Compounds for immunotherapy and diagnosis of breast cancer and methods for theiruse
|
US20020147143A1
(en)
|
1998-03-18 |
2002-10-10 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
AR020318A1
(es)
|
1998-03-18 |
2002-05-08 |
Corixa Corp |
Una molecula polinucleotidica aislada, un polipeptido aislado codificado por dicha molecula, un vector de expresion, una celula huesped transformada, unaproteina de fusion, una composicion farmaceutica y una vacuna que comprenden dicho polipeptido o proteina; metodos para el tratamiento, deteccion,
|
AU753995B2
(en)
|
1998-04-07 |
2002-10-31 |
Corixa Corporation |
Fusion proteins of mycobacterium tuberculosis antigens and their uses
|
WO1999052708A1
(en)
|
1998-04-13 |
1999-10-21 |
Luminex Corporation |
Liquid labeling with fluorescent microparticles
|
US7128927B1
(en)
|
1998-04-14 |
2006-10-31 |
Qlt Usa, Inc. |
Emulsions for in-situ delivery systems
|
GB9810236D0
(en)
|
1998-05-13 |
1998-07-08 |
Microbiological Res Authority |
Improvements relating to encapsulation of bioactive agents
|
US6406719B1
(en)
|
1998-05-13 |
2002-06-18 |
Microbiological Research Authority |
Encapsulation of bioactive agents
|
KR100293504B1
(ko)
|
1998-06-05 |
2001-07-12 |
김윤 |
서방형전립선염치료제조성물
|
JP2002524108A
(ja)
|
1998-07-28 |
2002-08-06 |
インナーダイン, インコーポレイテッド |
吸収性近接照射療法および化学療法送達デバイスならびに方法
|
EP1102790B1
(de)
|
1998-08-07 |
2014-05-07 |
University of Washington |
Immunologische Herpes Simplex Virus Antigene und Verfahren für deren Verwendung
|
US6013122A
(en)
*
|
1998-08-18 |
2000-01-11 |
Option Technologies, Inc. |
Tattoo inks
|
US20030235557A1
(en)
|
1998-09-30 |
2003-12-25 |
Corixa Corporation |
Compositions and methods for WT1 specific immunotherapy
|
WO2000030592A1
(en)
|
1998-11-20 |
2000-06-02 |
The General Hospital Corporation |
Permanent, removable tissue markings
|
US20040009535A1
(en)
|
1998-11-27 |
2004-01-15 |
Celltech R&D, Inc. |
Compositions and methods for increasing bone mineralization
|
CN100365120C
(zh)
|
1998-12-08 |
2008-01-30 |
科里克萨有限公司 |
用于治疗及诊断衣原体感染的化合物和方法
|
US20020119158A1
(en)
|
1998-12-17 |
2002-08-29 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
US6579973B1
(en)
|
1998-12-28 |
2003-06-17 |
Corixa Corporation |
Compositions for the treatment and diagnosis of breast cancer and methods for their use
|
ATE399793T1
(de)
|
1999-04-02 |
2008-07-15 |
Corixa Corp |
Verbindungen und verfahren für therapie und diagnose von lungenkrebs
|
US8143386B2
(en)
*
|
1999-04-07 |
2012-03-27 |
Corixa Corporation |
Fusion proteins of mycobacterium tuberculosis antigens and their uses
|
US6306425B1
(en)
|
1999-04-09 |
2001-10-23 |
Southern Research Institute |
Injectable naltrexone microsphere compositions and their use in reducing consumption of heroin and alcohol
|
WO2001024820A1
(en)
*
|
1999-10-07 |
2001-04-12 |
Corixa Corporation |
Fusion proteins of mycobacterium tuberculosis
|
US6458387B1
(en)
*
|
1999-10-18 |
2002-10-01 |
Epic Therapeutics, Inc. |
Sustained release microspheres
|
US20050037086A1
(en)
*
|
1999-11-19 |
2005-02-17 |
Zycos Inc., A Delaware Corporation |
Continuous-flow method for preparing microparticles
|
US6682754B2
(en)
|
1999-11-24 |
2004-01-27 |
Willmar Poultry Company, Inc. |
Ovo delivery of an immunogen containing implant
|
US6575888B2
(en)
|
2000-01-25 |
2003-06-10 |
Biosurface Engineering Technologies, Inc. |
Bioabsorbable brachytherapy device
|
CA2398668C
(en)
|
2000-02-17 |
2010-06-15 |
3M Innovative Properties Company |
Delivery systems using preformed biodegradable polymer compositions and methods
|
IL151097A0
(en)
|
2000-02-23 |
2003-04-10 |
Smithkline Beecham Biolog |
Tumour-specific animal proteins
|
AU2001241738A1
(en)
*
|
2000-02-25 |
2001-09-03 |
Corixa Corporation |
Compounds and methods for diagnosis and immunotherapy of tuberculosis
|
US20040002068A1
(en)
|
2000-03-01 |
2004-01-01 |
Corixa Corporation |
Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
|
ES2303525T3
(es)
|
2000-04-21 |
2008-08-16 |
Corixa Corporation |
Compuestos y metodos para el tratamiento y diagnostico de infeccion por chlamydia.
|
EP1292285A4
(de)
*
|
2000-06-02 |
2009-07-22 |
Eisai Corp North America |
Darreichungssystem für bioaktive stoffe
|
ATE442866T1
(de)
*
|
2000-06-20 |
2009-10-15 |
Corixa Corp |
Fusionsproteine aus mycobakterium tuberculosis
|
JP2004513615A
(ja)
|
2000-06-28 |
2004-05-13 |
コリクサ コーポレイション |
肺癌の治療および診断のための組成物および方法
|
KR100392501B1
(ko)
*
|
2000-06-28 |
2003-07-22 |
동국제약 주식회사 |
다중 에멀젼법에 의한 서방출성 미립구의 제조방법
|
US20040158317A1
(en)
*
|
2000-07-18 |
2004-08-12 |
Pharmasonics, Inc. |
Coated stent with ultrasound therapy
|
US6296842B1
(en)
|
2000-08-10 |
2001-10-02 |
Alkermes Controlled Therapeutics, Inc. |
Process for the preparation of polymer-based sustained release compositions
|
US6479065B2
(en)
|
2000-08-10 |
2002-11-12 |
Alkermes Controlled Therapeutics, Inc. |
Process for the preparation of polymer-based sustained release compositions
|
US6824822B2
(en)
|
2001-08-31 |
2004-11-30 |
Alkermes Controlled Therapeutics Inc. Ii |
Residual solvent extraction method and microparticles produced thereby
|
DE60138641D1
(de)
|
2000-10-27 |
2009-06-18 |
Baxter Healthcare Sa |
Herstellung von mikrokügelchen
|
US20040122090A1
(en)
*
|
2001-12-07 |
2004-06-24 |
Lipton Stuart A. |
Methods for treating neuropsychiatric disorders with nmda receptor antagonists
|
EP1343480B2
(de)
|
2000-12-21 |
2016-02-17 |
Alrise Biosystems GmbH |
Verfahren umfassend einen induzierten phasenübergang zur herstellung von hydrophobe wirkstoffe enthaltenden mikropartikeln
|
US20030033007A1
(en)
*
|
2000-12-22 |
2003-02-13 |
Avantec Vascular Corporation |
Methods and devices for delivery of therapeutic capable agents with variable release profile
|
US20030050692A1
(en)
*
|
2000-12-22 |
2003-03-13 |
Avantec Vascular Corporation |
Delivery of therapeutic capable agents
|
US7077859B2
(en)
*
|
2000-12-22 |
2006-07-18 |
Avantec Vascular Corporation |
Apparatus and methods for variably controlled substance delivery from implanted prostheses
|
US20050203612A1
(en)
*
|
2000-12-22 |
2005-09-15 |
Avantec Vascular Corporation |
Devices delivering therapeutic agents and methods regarding the same
|
US7083642B2
(en)
|
2000-12-22 |
2006-08-01 |
Avantec Vascular Corporation |
Delivery of therapeutic capable agents
|
US20020082678A1
(en)
*
|
2000-12-22 |
2002-06-27 |
Motasim Sirhan |
Intravascular delivery of mizoribine
|
US20020082679A1
(en)
*
|
2000-12-22 |
2002-06-27 |
Avantec Vascular Corporation |
Delivery or therapeutic capable agents
|
US6471980B2
(en)
|
2000-12-22 |
2002-10-29 |
Avantec Vascular Corporation |
Intravascular delivery of mycophenolic acid
|
US7018405B2
(en)
|
2000-12-22 |
2006-03-28 |
Avantec Vascular Corporation |
Intravascular delivery of methylprednisolone
|
US6939375B2
(en)
|
2000-12-22 |
2005-09-06 |
Avantac Vascular Corporation |
Apparatus and methods for controlled substance delivery from implanted prostheses
|
US7829084B2
(en)
*
|
2001-01-17 |
2010-11-09 |
Trubion Pharmaceuticals, Inc. |
Binding constructs and methods for use thereof
|
AU2002241922B2
(en)
|
2001-01-17 |
2007-10-25 |
Aptevo Research And Development Llc |
Binding domain-immunoglobulin fusion proteins
|
US7754208B2
(en)
|
2001-01-17 |
2010-07-13 |
Trubion Pharmaceuticals, Inc. |
Binding domain-immunoglobulin fusion proteins
|
US7618939B2
(en)
*
|
2001-02-15 |
2009-11-17 |
The Board Of Trustees Of The University Of Illinois |
Compositions and methods to prevent cancer with cupredoxins
|
US7491394B2
(en)
|
2001-02-15 |
2009-02-17 |
The Board Of Trustees Of The University Of Illinois |
Cytotoxic factors for modulating cell death
|
US7041046B2
(en)
*
|
2001-05-07 |
2006-05-09 |
Xoft, Inc. |
Combination ionizing radiation and immunomodulator delivery devices and methods for inhibiting hyperplasia
|
US6537195B2
(en)
|
2001-05-07 |
2003-03-25 |
Xoft, Microtube, Inc. |
Combination x-ray radiation and drug delivery devices and methods for inhibiting hyperplasia
|
WO2002089747A2
(en)
|
2001-05-09 |
2002-11-14 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
JP2004535431A
(ja)
|
2001-06-22 |
2004-11-25 |
サザン バイオシステムズ, インコーポレイテッド |
ゼロ次長期放出同軸インプラント
|
US20030108565A1
(en)
|
2001-07-10 |
2003-06-12 |
Johnson Mark E. |
Compositions and methods for delivery of proteins and adjuvants encapsulated in microspheres
|
JP4347044B2
(ja)
*
|
2001-07-26 |
2009-10-21 |
アバンテク バスキュラー コーポレーション |
可変放出プロフィールを有する治療用薬剤を送達するための装置
|
US20080026068A1
(en)
*
|
2001-08-16 |
2008-01-31 |
Baxter Healthcare S.A. |
Pulmonary delivery of spherical insulin microparticles
|
ATE395042T1
(de)
*
|
2001-08-16 |
2008-05-15 |
Baxter Int |
Darreichungsformen welche mikropartikel und treibgas enthalten
|
AU2002336533B2
(en)
|
2001-09-13 |
2007-04-26 |
Ansell Healthcare Products Llc |
Microencapsulation coating for gloves
|
NZ532027A
(en)
|
2001-10-10 |
2008-09-26 |
Neose Technologies Inc |
Remodeling and glycoconjugation of peptides
|
CN105131104B
(zh)
|
2001-10-10 |
2018-11-16 |
诺和诺德公司 |
肽的重构和糖缀合
|
EP2316466B1
(de)
|
2001-12-11 |
2013-08-21 |
Institut Pasteur |
Behandlung von Immundysregulations-Erkrankungen mit einer Zusammensetzung aus Gram-positiven Bakterien
|
CA2476755C
(en)
|
2001-12-17 |
2014-08-26 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
|
AU2003210787B2
(en)
|
2002-02-01 |
2009-04-23 |
Medinol Ltd. |
Phosphorus-containing compounds & uses thereof
|
US7026465B2
(en)
|
2002-02-15 |
2006-04-11 |
Corixa Corporation |
Fusion proteins of Mycobacterium tuberculosis
|
US7157102B1
(en)
|
2002-05-31 |
2007-01-02 |
Biotek, Inc. |
Multi-layered microcapsules and method of preparing same
|
US7736665B2
(en)
*
|
2002-05-31 |
2010-06-15 |
Titan Pharmaceuticals, Inc. |
Implantable polymeric device for sustained release of buprenorphine
|
US7041320B1
(en)
|
2002-05-31 |
2006-05-09 |
Biotek, Inc. |
High drug loaded injectable microparticle compositions and methods of treating opioid drug dependence
|
ATE494907T1
(de)
|
2002-07-18 |
2011-01-15 |
Univ Washington |
Pharmazeutische zusammensetzungen, die immunologisch aktive herpes simplex virus proteinfragmente enthalten
|
US7736391B2
(en)
|
2003-02-06 |
2010-06-15 |
Tonaba Healthscience Ii, Llc |
Cosmetic and reconstructive prostheses with a microencapsulated biologically compatible rupture indicator for sustained release and methods of detecting compromise of a prosthesis
|
MX295545B
(es)
|
2003-03-07 |
2012-02-03 |
Diversa Corp |
Hidrolasas, acidos nucleicos que las codifican, y metodos para hacerlas y usarlas.
|
KR20060003862A
(ko)
|
2003-03-14 |
2006-01-11 |
네오스 테크놀로지스, 인크. |
수용성분기폴리머 및 그 접합체
|
NZ542548A
(en)
|
2003-03-31 |
2009-04-30 |
Titan Pharmaceuticals Inc |
Implantable polymeric device for sustained release of dopamine agonist
|
US20040254419A1
(en)
*
|
2003-04-08 |
2004-12-16 |
Xingwu Wang |
Therapeutic assembly
|
US20070010702A1
(en)
*
|
2003-04-08 |
2007-01-11 |
Xingwu Wang |
Medical device with low magnetic susceptibility
|
US20070026485A1
(en)
|
2003-04-09 |
2007-02-01 |
Neose Technologies, Inc. |
Glycopegylation methods and proteins/peptides produced by the methods
|
US20070207211A1
(en)
*
|
2003-04-10 |
2007-09-06 |
Pr Pharmaceuticals, Inc. |
Emulsion-based microparticles and methods for the production thereof
|
ES2427092T3
(es)
*
|
2003-04-10 |
2013-10-28 |
Evonik Corporation |
Un método para la producción de micropartículas a base de emulsión
|
US20060193825A1
(en)
*
|
2003-04-29 |
2006-08-31 |
Praecis Phamaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
US20050112087A1
(en)
*
|
2003-04-29 |
2005-05-26 |
Musso Gary F. |
Pharmaceutical formulations for sustained drug delivery
|
NZ544618A
(en)
|
2003-06-16 |
2009-02-28 |
Celltech R & D Inc |
Antibodies specific for sclerostin and methods for increasing bone mineralization
|
CA2532302C
(en)
*
|
2003-07-15 |
2016-12-20 |
Pr Pharmaceuticals, Inc. |
Method for the preparation of controlled release formulations
|
SG135204A1
(en)
*
|
2003-07-18 |
2007-09-28 |
Baxter Int |
Methods for fabrication, uses and compositions of small spherical particles prepared by controlled phase separation
|
US20050142205A1
(en)
*
|
2003-07-18 |
2005-06-30 |
Julia Rashba-Step |
Methods for encapsulating small spherical particles prepared by controlled phase separation
|
US20070092452A1
(en)
*
|
2003-07-18 |
2007-04-26 |
Julia Rashba-Step |
Methods for fabrication, uses, compositions of inhalable spherical particles
|
EP1646354A4
(de)
*
|
2003-07-22 |
2010-03-17 |
Baxter Int |
Kleine kugelförmige teilchen von niedermolekularen organischen molekülen und herstellungs- und anwendungsverfahren dafür
|
BRPI0412211A
(pt)
*
|
2003-07-23 |
2006-08-22 |
Pr Pharmaceuticals Inc |
composições de liberação controlada
|
US20070149496A1
(en)
*
|
2003-10-31 |
2007-06-28 |
Jack Tuszynski |
Water-soluble compound
|
WO2005051229A2
(en)
*
|
2003-11-24 |
2005-06-09 |
Avantec Vascular Corporation |
Devices delivering therapeutic agents and methods regarding the same
|
US7999071B2
(en)
|
2003-12-12 |
2011-08-16 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Human cytotoxic T-lymphoctye epitope and its agonist eptiope from the non-variable number of tandem repeat sequence of MUC-1
|
TW200529890A
(en)
*
|
2004-02-10 |
2005-09-16 |
Takeda Pharmaceutical |
Sustained-release preparations
|
MXPA06009377A
(es)
|
2004-02-20 |
2007-03-07 |
Lifescape Biosciences Inc |
Composiciones y metodos para regulacion del sueno.
|
ATE534424T1
(de)
*
|
2004-03-19 |
2011-12-15 |
Abbott Lab |
Mehrfache arzneiabgabe aus einem ballon und eine prothese
|
US20070027523A1
(en)
*
|
2004-03-19 |
2007-02-01 |
Toner John L |
Method of treating vascular disease at a bifurcated vessel using coated balloon
|
US8431145B2
(en)
|
2004-03-19 |
2013-04-30 |
Abbott Laboratories |
Multiple drug delivery from a balloon and a prosthesis
|
US20100030183A1
(en)
*
|
2004-03-19 |
2010-02-04 |
Toner John L |
Method of treating vascular disease at a bifurcated vessel using a coated balloon
|
US20050249667A1
(en)
*
|
2004-03-24 |
2005-11-10 |
Tuszynski Jack A |
Process for treating a biological organism
|
CN1968700A
(zh)
|
2004-04-15 |
2007-05-23 |
阿尔克姆斯有限公司 |
聚合物基的持续释放装置
|
US7456254B2
(en)
*
|
2004-04-15 |
2008-11-25 |
Alkermes, Inc. |
Polymer-based sustained release device
|
US20050239723A1
(en)
*
|
2004-04-27 |
2005-10-27 |
Amin Avinash N |
Compositions and methods useful for treatment of acne
|
US8728525B2
(en)
*
|
2004-05-12 |
2014-05-20 |
Baxter International Inc. |
Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
|
WO2005112885A2
(en)
*
|
2004-05-12 |
2005-12-01 |
Baxter International Inc. |
Oligonucleotide-containing microspheres, their use for the manufacture of a medicament for treating diabetes type 1
|
WO2005112893A1
(en)
*
|
2004-05-12 |
2005-12-01 |
Baxter International Inc. |
Microspheres comprising protein and showing injectability at high concentrations of said agent
|
EP1765294B1
(de)
|
2004-05-12 |
2008-09-24 |
Baxter International Inc. |
Nukleinsäure-mikrokügelchen, ihre herstellung und abgabe
|
EP2497831B1
(de)
|
2004-05-25 |
2014-07-16 |
Oregon Health and Science University |
TB-Impfung unter Verwendung von Impfvektoren auf HCMV-Basis
|
US20060264411A1
(en)
*
|
2005-05-20 |
2006-11-23 |
Eldridge Gary R |
Control of biofilm formation
|
US7604978B2
(en)
*
|
2004-07-14 |
2009-10-20 |
Sequoia Sciences, Inc. |
Inhibition of biofilm formation
|
EP2848942B1
(de)
|
2004-07-14 |
2017-03-08 |
The Regents of The University of California |
Biomarker zur Früherkennung von Eierstockkrebs
|
US20060014285A1
(en)
*
|
2004-07-14 |
2006-01-19 |
Eldridge Gary R |
Methods and compositions for inhibiting biofilms
|
US9132116B2
(en)
|
2004-08-02 |
2015-09-15 |
Willowcroft Pharm Inc. |
Mast cell stabilizers to prevent or treat laminitis
|
AU2005325213B2
(en)
*
|
2004-08-04 |
2010-10-07 |
Evonik Corporation |
Methods for manufacturing delivery devices and devices thereof
|
CA2580078A1
(en)
|
2004-09-14 |
2006-03-23 |
Gary R. Eldridge |
Compounds, compositions and methods for controlling biofilms and bacterial infections
|
EP2808384B1
(de)
|
2004-10-08 |
2017-12-06 |
The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services |
Modulation der Replikationsrate durch Verwendung von seltener verwendeten synonymen Kodonen
|
US7619007B2
(en)
|
2004-11-23 |
2009-11-17 |
Adamas Pharmaceuticals, Inc. |
Method and composition for administering an NMDA receptor antagonist to a subject
|
BRPI0518483A2
(pt)
|
2004-11-23 |
2008-11-18 |
Neuromolecular Pharmaceuticals Inc |
composiÇço compreendendo uma matriz ou revestimento de liberaÇço controlada e um antagonista de receptor de nmda, mÉtodo para administraÇço de tal antagonista de nmda a um paciente
|
EP1845968A2
(de)
|
2004-11-24 |
2007-10-24 |
Neuromolecular Pharmaceuticals, Inc |
Zusammensetzung mit einem nmda-rezeptor-antagonisten und levodopa und ihre verwendung zur behandlung von neurologischen erkrankungen
|
ES2449195T3
(es)
|
2005-01-10 |
2014-03-18 |
Ratiopharm Gmbh |
Factor estimulante de colonias de granulocitos glicopegilado
|
US20070150051A1
(en)
*
|
2005-01-10 |
2007-06-28 |
Duke Fiduciary, Llc |
Vascular implants and methods of fabricating the same
|
US8287583B2
(en)
*
|
2005-01-10 |
2012-10-16 |
Taheri Laduca Llc |
Apparatus and method for deploying an implantable device within the body
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
US9050393B2
(en)
*
|
2005-02-08 |
2015-06-09 |
Bruce N. Saffran |
Medical devices and methods for modulation of physiology using device-based surface chemistry
|
EP1701165A1
(de)
|
2005-03-07 |
2006-09-13 |
Johannes Dr. Coy |
Therapeutischer und diagnostischer Gebrauch von TKTL1 sowie seiner Inhibitoren und Aktivatoren
|
WO2006104890A2
(en)
|
2005-03-31 |
2006-10-05 |
Glaxosmithkline Biologicals Sa |
Vaccines against chlamydial infection
|
US20060228384A1
(en)
*
|
2005-04-06 |
2006-10-12 |
Sequoia Sciences, Inc. |
Control of biofilm with a biofilm inhibitor
|
JP5666087B2
(ja)
|
2005-04-06 |
2015-02-12 |
アダマス・ファーマシューティカルズ・インコーポレーテッド |
Cns関連疾患の治療のための方法及び組成物
|
EP2386571B1
(de)
|
2005-04-08 |
2016-06-01 |
ratiopharm GmbH |
Zusammensetzungen und Verfahren zur Herstellung von Glycosylierungsmutanten eines Proteaseresistenten menschlichen Wachstumshormons
|
EP1885335A1
(de)
*
|
2005-04-27 |
2008-02-13 |
BAXTER INTERNATIONAL INC. (a Delaware corporation) |
Oberflächenmodifizierte mikroteilchen und verfahren zu ihrer bildung und verwendung
|
JP5164830B2
(ja)
|
2005-04-29 |
2013-03-21 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
結核菌感染の予防または治療のための新規方法
|
EP2305701A1
(de)
|
2005-07-01 |
2011-04-06 |
Forsyth Dental Infirmary for Children |
Assays zur Detektion von Tuberkuloseantigenen und Impfstoffe
|
KR100741867B1
(ko)
*
|
2005-07-05 |
2007-07-24 |
전북대학교산학협력단 |
수중유적 및 용매 증발법을 이용한 이중층 미립구의제조방법
|
US20070014739A1
(en)
*
|
2005-07-14 |
2007-01-18 |
Eldridge Gary R |
Compositions and methods for controlling biofilms and bacterial infections
|
WO2007014169A2
(en)
|
2005-07-22 |
2007-02-01 |
Y's Therapeutics Co, Ltd. |
Anti-cd26 antibodies and methods of use thereof
|
DK1912675T3
(en)
|
2005-07-25 |
2014-03-24 |
Emergent Product Dev Seattle |
B-cell reduction using specific and cd37-cd20-specific binding molecules
|
US20090099031A1
(en)
*
|
2005-09-27 |
2009-04-16 |
Stemmer Willem P |
Genetic package and uses thereof
|
US7855279B2
(en)
*
|
2005-09-27 |
2010-12-21 |
Amunix Operating, Inc. |
Unstructured recombinant polymers and uses thereof
|
US7846445B2
(en)
*
|
2005-09-27 |
2010-12-07 |
Amunix Operating, Inc. |
Methods for production of unstructured recombinant polymers and uses thereof
|
AU2006294644A1
(en)
*
|
2005-09-27 |
2007-04-05 |
Amunix, Inc. |
Proteinaceous pharmaceuticals and uses thereof
|
CN103251929A
(zh)
*
|
2005-12-22 |
2013-08-21 |
诺瓦提斯公司 |
包含奥曲肽和两种或更多种聚丙交酯-共-乙交酯聚合物的缓释制剂
|
EP1981525B1
(de)
*
|
2005-12-30 |
2015-01-21 |
Zensun (Shanghai) Science and Technology Limited |
Verlängerte freisetzung von neuregulin für verbesserte herzfunktion
|
WO2007079755A1
(en)
|
2006-01-12 |
2007-07-19 |
Janus Beierholm Holding Aps |
Reimmunization and antibody design
|
EP1981905B1
(de)
|
2006-01-16 |
2016-08-31 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Chlamydia-impfstoff
|
WO2007092314A2
(en)
|
2006-02-02 |
2007-08-16 |
Verenium Corporation |
Esterases and related nucleic acids and methods
|
WO2007109583A2
(en)
|
2006-03-17 |
2007-09-27 |
The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subject
|
EP2010226B1
(de)
|
2006-04-07 |
2014-01-15 |
The Research Foundation of State University of New York |
Transcobalaminrezeptor-Polypeptide, -Nukleinsäuren und -Modulatoren sowie entsprechende Verfahren zur Verwendung für die Modulation von Zellwachstum und die Behandlung von Krebs und Cobalaminmangel
|
US8859233B2
(en)
*
|
2006-05-02 |
2014-10-14 |
Carviar Aps |
Method for immunizing an avian species
|
US10522240B2
(en)
|
2006-05-03 |
2019-12-31 |
Population Bio, Inc. |
Evaluating genetic disorders
|
US7702468B2
(en)
|
2006-05-03 |
2010-04-20 |
Population Diagnostics, Inc. |
Evaluating genetic disorders
|
US20070281031A1
(en)
*
|
2006-06-01 |
2007-12-06 |
Guohan Yang |
Microparticles and methods for production thereof
|
US8323676B2
(en)
*
|
2008-06-30 |
2012-12-04 |
Abbott Cardiovascular Systems Inc. |
Poly(ester-amide) and poly(amide) coatings for implantable medical devices for controlled release of a protein or peptide and a hydrophobic drug
|
US20090258028A1
(en)
*
|
2006-06-05 |
2009-10-15 |
Abbott Cardiovascular Systems Inc. |
Methods Of Forming Coatings For Implantable Medical Devices For Controlled Release Of A Peptide And A Hydrophobic Drug
|
JP2009539413A
(ja)
*
|
2006-06-12 |
2009-11-19 |
トゥルビオン・ファーマシューティカルズ・インコーポレーテッド |
エフェクター機能を有する単鎖多価結合タンパク質
|
US8017237B2
(en)
|
2006-06-23 |
2011-09-13 |
Abbott Cardiovascular Systems, Inc. |
Nanoshells on polymers
|
MX2009001226A
(es)
*
|
2006-08-04 |
2009-03-20 |
Baxter Int |
Composicion basada en microesferas para prevenir y/o revertir la diabetes autoinmune de nuevo inicio.
|
KR101200728B1
(ko)
|
2006-08-09 |
2012-11-13 |
인타르시아 세라퓨틱스 인코포레이티드 |
삼투성 전달 시스템 및 피스톤 조립체
|
US20090181078A1
(en)
|
2006-09-26 |
2009-07-16 |
Infectious Disease Research Institute |
Vaccine composition containing synthetic adjuvant
|
SI2484375T1
(en)
|
2006-09-26 |
2018-08-31 |
Infectious Disease Research Institute |
A vaccine composition comprising a synthetic adjuvant
|
JP5457185B2
(ja)
|
2006-10-04 |
2014-04-02 |
ノヴォ ノルディスク アー/エス |
グリセロール連結のpeg化された糖および糖ペプチド
|
AU2007319577A1
(en)
*
|
2006-10-06 |
2008-05-22 |
Baxter Healthcare S.A. |
Microencapsules containing surface-modified microparticles and methods of forming and using the same
|
BRPI0807260A2
(pt)
*
|
2007-02-09 |
2014-06-10 |
Taheri Laduca Llc |
"stent implantável e método de fabricação de um enxerto tubular"
|
CN101686939B
(zh)
*
|
2007-04-17 |
2013-03-27 |
巴克斯特国际公司 |
用于肺部投送的核酸微粒
|
AU2008244523B2
(en)
|
2007-04-23 |
2012-02-16 |
Intarcia Therapeutics, Inc. |
Suspension formulations of insulinotropic peptides and uses thereof
|
RS58248B1
(sr)
*
|
2007-06-06 |
2019-03-29 |
Debiopharm Res & Manufacturing Sa |
Farmaceutska kompozicija sa sporim oslobađanjem pripremljena od mikročestica
|
CN101990439A
(zh)
*
|
2007-07-06 |
2011-03-23 |
特鲁比昂药品公司 |
具有置于c末端的特异性结合结构域的结合肽
|
KR20100058541A
(ko)
*
|
2007-08-15 |
2010-06-03 |
아뮤닉스 인코포레이티드 |
생물학적 활성 폴리펩티드의 특성을 변경하기 위한 조성물 및 방법
|
WO2009044402A1
(en)
*
|
2007-10-02 |
2009-04-09 |
Ariel - University Research And Development Company Ltd. |
Endocannabinoids for enhancing growth and development in infants
|
US8932558B2
(en)
*
|
2007-10-05 |
2015-01-13 |
Plaxgen Inc |
Multi-subunit biological complexes for treatment of plaque-associated diseases
|
US7828840B2
(en)
*
|
2007-11-15 |
2010-11-09 |
Med Institute, Inc. |
Medical devices and methods for local delivery of angiotensin II type 2 receptor antagonists
|
JP2011503213A
(ja)
*
|
2007-11-19 |
2011-01-27 |
カプスレイテッド システムズ インコーポレイテッド |
マイクロ粒子を使用する局所麻酔薬の持続放出および手術適用方法
|
US8619257B2
(en)
|
2007-12-13 |
2013-12-31 |
Kimberley-Clark Worldwide, Inc. |
Recombinant bacteriophage for detection of nosocomial infection
|
ES2718612T3
(es)
|
2007-12-20 |
2019-07-03 |
Evonik Corp |
Procedimiento para preparar micropartículas que tienen un bajo volumen de disolvente residual
|
EP2240155B1
(de)
|
2008-02-13 |
2012-06-06 |
Intarcia Therapeutics, Inc |
Vorrichtungen, formulierungen und verfahren zur freisetzung mehrerer wirkstoffe
|
EP2274437B1
(de)
|
2008-04-10 |
2015-12-23 |
Cell Signaling Technology, Inc. |
Zusammensetzungen und verfahren zur erkennung von egfr-mutationen bei krebs
|
ES2368700T3
(es)
*
|
2008-04-11 |
2011-11-21 |
Emergent Product Development Seattle, Llc |
Agente inmunoterapéutico para cd37 y combinación con un agente quimioterapéutico bifuncional del mismo.
|
EP2982753B1
(de)
|
2008-04-18 |
2018-06-06 |
Baxter International Inc. |
Zusammensetzung auf mikrokügelchenbasis zur vorbeugung und/oder abwendung einer neuerkrankung an autoimmunem diabetes
|
EP2123748A1
(de)
|
2008-05-20 |
2009-11-25 |
Institut Pasteur |
2'-5'-Oligoadenylat-Synthetase 3 zur Vorbeugung und Behandlung von positivgerichteten einsträngigen RNA-Virusinfektionen
|
US8765162B2
(en)
|
2008-06-30 |
2014-07-01 |
Abbott Cardiovascular Systems Inc. |
Poly(amide) and poly(ester-amide) polymers and drug delivery particles and coatings containing same
|
US8367427B2
(en)
*
|
2008-08-20 |
2013-02-05 |
Baxter International Inc. |
Methods of processing compositions containing microparticles
|
US8323685B2
(en)
*
|
2008-08-20 |
2012-12-04 |
Baxter International Inc. |
Methods of processing compositions containing microparticles
|
US20100047292A1
(en)
*
|
2008-08-20 |
2010-02-25 |
Baxter International Inc. |
Methods of processing microparticles and compositions produced thereby
|
US8323615B2
(en)
*
|
2008-08-20 |
2012-12-04 |
Baxter International Inc. |
Methods of processing multi-phasic dispersions
|
US8198062B2
(en)
*
|
2008-08-29 |
2012-06-12 |
Dsm Ip Assets B.V. |
Hydrolases, nucleic acids encoding them and methods for making and using them
|
US8357503B2
(en)
|
2008-08-29 |
2013-01-22 |
Bunge Oils, Inc. |
Hydrolases, nucleic acids encoding them and methods for making and using them
|
US8153391B2
(en)
|
2008-08-29 |
2012-04-10 |
Bunge Oils, Inc. |
Hydrolases, nucleic acids encoding them and methods for making and using them
|
US8268887B2
(en)
|
2008-10-08 |
2012-09-18 |
Feng Xu |
Drug conjugates and methods of use thereof
|
CA2749997A1
(en)
*
|
2009-01-23 |
2010-07-29 |
Surmodics Pharmaceuticals, Inc. |
Polymer mixtures comprising polymers having different non-repeating units and methods for making and using same
|
US20100189763A1
(en)
*
|
2009-01-23 |
2010-07-29 |
Heather Nettles |
Controlled release systems from polymer blends
|
CN116925238A
(zh)
|
2009-02-03 |
2023-10-24 |
阿穆尼克斯制药公司 |
延伸重组多肽和包含该延伸重组多肽的组合物
|
EP2418945B1
(de)
|
2009-04-15 |
2018-12-05 |
BMG PHARMA S.p.A. |
Mineralsalz-schwefelsäure-zusammensetzungen und verfahren zu ihrer verwendung
|
WO2010141861A1
(en)
|
2009-06-05 |
2010-12-09 |
Infectious Disease Research Institute |
Synthetic glucopyranosyl lipid adjuvants
|
US20110038852A1
(en)
*
|
2009-06-10 |
2011-02-17 |
3-V Biosciences, Inc. |
Antivirals that target transporters, carriers, and ion channels
|
US8911766B2
(en)
*
|
2009-06-26 |
2014-12-16 |
Abbott Cardiovascular Systems Inc. |
Drug delivery compositions including nanoshells for triggered drug release
|
EP2292260A1
(de)
|
2009-08-13 |
2011-03-09 |
Institut Pasteur |
Verwendung des durch erweiterte Gefriertrocknung (EFD) abgetöteten Mycobakteriums bovis BCG zur Vorbeugung und Behandlung von Atherosklerose
|
CN102741422B
(zh)
|
2009-08-24 |
2016-06-08 |
阿穆尼克斯运营公司 |
凝血因子ⅶ组合物及其制备和使用方法
|
ES2538007T3
(es)
|
2009-09-16 |
2015-06-16 |
Vaxart, Inc. |
Estrategia de inmunización para prevenir una infección por H1N1
|
RU2012115120A
(ru)
*
|
2009-09-17 |
2013-10-27 |
Евоник Дегусса Корпорейшн |
Имплантируемые устройства, которые отличаются профилем высвобождения, и способы их изготовления и применения
|
BR112012006443A2
(pt)
*
|
2009-09-22 |
2017-07-25 |
Evonik Degussa Corp |
dispositivos de implante que apresentam configurações de cargas variáveis de agentes bioativos
|
SI2462246T1
(en)
|
2009-09-28 |
2018-01-31 |
Intarcia Therapeutics, Inc. |
Fast-setting and / or cessation of substantially unchanged delivery of the product
|
KR20120100964A
(ko)
|
2009-09-30 |
2012-09-12 |
바이타패스 제네틱스 인코포레이티드 |
개인용 보조인자 및 사용 방법
|
CA2778678A1
(en)
|
2009-10-30 |
2011-05-05 |
Cns Therapeutics, Inc. |
Improved neurturin molecules
|
US20110104138A1
(en)
|
2009-11-03 |
2011-05-05 |
Institut Pasteur |
Use of the innate immunity gene oasl for preventing or treating infection with negative strand rna viruses
|
KR101773636B1
(ko)
|
2009-11-19 |
2017-09-01 |
솔리스 바이오다인 |
폴리펩티드 안정성 및 활성을 증가시키는 조성물 및 관련된 방법
|
CN102883601A
(zh)
|
2009-12-02 |
2013-01-16 |
阿达玛斯医药公司 |
金刚烷胺组合物及其使用方法
|
US8951595B2
(en)
*
|
2009-12-11 |
2015-02-10 |
Abbott Cardiovascular Systems Inc. |
Coatings with tunable molecular architecture for drug-coated balloon
|
US20110144577A1
(en)
*
|
2009-12-11 |
2011-06-16 |
John Stankus |
Hydrophilic coatings with tunable composition for drug coated balloon
|
US8480620B2
(en)
*
|
2009-12-11 |
2013-07-09 |
Abbott Cardiovascular Systems Inc. |
Coatings with tunable solubility profile for drug-coated balloon
|
KR20130088002A
(ko)
|
2010-01-13 |
2013-08-07 |
재단법인 한국파스퇴르연구소 |
항-감염성 피리도(1,2-a)피리미딘
|
HUE031184T2
(en)
|
2010-01-27 |
2017-06-28 |
Glaxosmithkline Biologicals Sa |
Modified tuberculosis antigens
|
US9556248B2
(en)
|
2010-03-19 |
2017-01-31 |
The Board Of Trustees Of The Leland Stanford Junior University |
Hepatocyte growth factor fragments that function as potent met receptor agonists and antagonists
|
US9295663B2
(en)
|
2010-07-14 |
2016-03-29 |
Abbott Cardiovascular Systems Inc. |
Drug coated balloon with in-situ formed drug containing microspheres
|
WO2012018387A2
(en)
|
2010-08-02 |
2012-02-09 |
Population Diagnotics, Inc. |
Compositions and methods for discovery of causative mutations in genetic disorders
|
JP2013544600A
(ja)
|
2010-11-23 |
2013-12-19 |
プレサージュ バイオサイエンシズ,インコーポレイテッド |
固体デリバリーのための治療方法および組成物
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
KR101930106B1
(ko)
|
2011-03-08 |
2018-12-17 |
3-브이 바이오사이언시스, 인코포레이티드 |
지질 합성의 헤테로사이클릭 조절자
|
EP2683736B1
(de)
|
2011-03-09 |
2018-01-17 |
Cell Signaling Technology, Inc. |
Verfahren und reagenzien zur erzeugung monoklonaler antikörper
|
NZ616304A
(en)
|
2011-04-08 |
2016-01-29 |
Immune Design Corp |
Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
|
US8697085B2
(en)
|
2011-06-17 |
2014-04-15 |
University Of Tennessee Research Foundation |
Group A Streptococcus multivalent vaccine
|
WO2012177595A1
(en)
|
2011-06-21 |
2012-12-27 |
Oncofactor Corporation |
Compositions and methods for the therapy and diagnosis of cancer
|
MX2014000419A
(es)
|
2011-07-15 |
2014-09-22 |
Nusirt Sciences Inc |
Composicones y metodos para modular trayectorias metabolicas.
|
US8324264B1
(en)
|
2011-07-22 |
2012-12-04 |
Sequoia Sciences, Inc. |
Inhibitors of bacterial biofilms and related methods
|
US10221454B2
(en)
|
2011-10-10 |
2019-03-05 |
The Hospital For Sick Children |
Methods and compositions for screening and treating developmental disorders
|
JP2014534864A
(ja)
|
2011-10-28 |
2014-12-25 |
プレサージュ バイオサイエンシズ,インコーポレイテッド |
薬物デリバリー方法
|
WO2013067451A2
(en)
|
2011-11-04 |
2013-05-10 |
Population Diagnostics Inc. |
Methods and compositions for diagnosing, prognosing, and treating neurological conditions
|
BR112014011417B1
(pt)
|
2011-11-11 |
2021-10-13 |
Fred Hutchinson Cancer Research Center |
Polipeptídeo isolado capaz de elicitar uma resposta de célula t antígeno-específica para ciclina a1 humana, composição imunogênica compreendendo o referido polipeptídeo, bem como método para preparar células apresentadoras de antígeno, antígeno-pulsadas,e uso destas para superexpressão de ccna1
|
EP3563834A1
(de)
|
2012-02-07 |
2019-11-06 |
Infectious Disease Research Institute |
Verbesserte adjuvansformulierungen mit tlr4-agonisten und verfahren zur verwendung davon
|
EP2812452B1
(de)
|
2012-02-09 |
2020-05-27 |
Population Bio, Inc. |
Verfahren und zusammensetzungen zum screening und zur behandlung von entwicklungsstörungen
|
JP6256882B2
(ja)
|
2012-02-15 |
2018-01-10 |
アムニクス オペレーティング インコーポレイテッド |
第viii因子組成物、ならびに組成物の作製方法および用途
|
JP6383666B2
(ja)
|
2012-02-15 |
2018-08-29 |
バイオベラティブ セラピューティクス インコーポレイテッド |
組換え第viii因子タンパク質
|
US9173910B2
(en)
|
2012-02-29 |
2015-11-03 |
The General Hospital Corporation |
Compositions of microbiota and methods related thereto
|
US9198454B2
(en)
|
2012-03-08 |
2015-12-01 |
Nusirt Sciences, Inc. |
Compositions, methods, and kits for regulating energy metabolism
|
WO2013134577A2
(en)
|
2012-03-08 |
2013-09-12 |
Detectogen, Inc. |
Leishmaniasis antigen detection assays and vaccines
|
AU2013262691B2
(en)
|
2012-05-16 |
2018-12-20 |
Immune Design Corp. |
Vaccines for HSV-2
|
US9976180B2
(en)
|
2012-09-14 |
2018-05-22 |
Population Bio, Inc. |
Methods for detecting a genetic variation in subjects with parkinsonism
|
CA2922005A1
(en)
|
2012-09-27 |
2014-04-03 |
Population Diagnostics, Inc. |
Methods and compositions for screening and treating developmental disorders
|
CN108452311A
(zh)
|
2012-11-13 |
2018-08-28 |
纽斯尔特科学公司 |
用于增强能量代谢的组合物和方法
|
CN105101958B
(zh)
|
2013-01-15 |
2019-05-17 |
纽斯尔特科学公司 |
治疗肺病状
|
CN105228627B
(zh)
|
2013-03-15 |
2018-07-13 |
纽斯尔特科学公司 |
亮氨酸和烟酸降低脂质水平
|
AU2014253791B2
(en)
|
2013-04-18 |
2019-05-02 |
Immune Design Corp. |
GLA monotherapy for use in cancer treatment
|
US9463198B2
(en)
|
2013-06-04 |
2016-10-11 |
Infectious Disease Research Institute |
Compositions and methods for reducing or preventing metastasis
|
US10154971B2
(en)
|
2013-06-17 |
2018-12-18 |
Adamas Pharma, Llc |
Methods of administering amantadine
|
US10231993B2
(en)
|
2013-06-27 |
2019-03-19 |
University Of Washington Through Its Center For Commercialization |
Biocompatible polymeric system for targeted treatment of thrombotic and hemostatic disorders
|
US10208125B2
(en)
|
2013-07-15 |
2019-02-19 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Anti-mucin 1 binding agents and uses thereof
|
CN105407728A
(zh)
|
2013-07-21 |
2016-03-16 |
霍勒拜欧姆公司 |
用于微生物组表征、监测和治疗的方法和系统
|
US10548953B2
(en)
|
2013-08-14 |
2020-02-04 |
Bioverativ Therapeutics Inc. |
Factor VIII-XTEN fusions and uses thereof
|
ES2841137T3
(es)
|
2013-12-20 |
2021-07-07 |
Sagimet Biosciences Inc |
Moduladores heterocíclicos de la síntesis de lípidos y combinaciones de los mismos
|
AU2015204907B2
(en)
|
2014-01-07 |
2018-08-02 |
Sagimet Biosciences Inc. |
Heterocyclic modulators of lipid synthesis for use against cancer and viral infections
|
CA2935722A1
(en)
|
2014-01-21 |
2015-07-30 |
Immune Design Corp. |
Compositions for use in the treatment of allergic conditions
|
JP6797692B2
(ja)
|
2014-02-20 |
2020-12-09 |
バクサート インコーポレイテッド |
小腸送達のための製剤
|
CN106456997B
(zh)
|
2014-02-27 |
2018-12-28 |
纽斯尔特科学公司 |
用于减少或预防肝性脂肪变性的组合物和方法
|
JP6737714B2
(ja)
|
2014-03-14 |
2020-08-12 |
ユニヴァーシティ オブ ワシントン |
ゲノムインスレーターエレメントおよびその使用
|
ES2868305T3
(es)
|
2014-03-28 |
2021-10-21 |
Univ Washington Through Its Center For Commercialization |
Vacunas contra el cáncer de mama y de ovario
|
EP3169699A4
(de)
|
2014-07-18 |
2018-06-20 |
The University of Washington |
Krebsimpfstoffzusammensetzungen und verfahren zur verwendung davon
|
US10724096B2
(en)
|
2014-09-05 |
2020-07-28 |
Population Bio, Inc. |
Methods and compositions for inhibiting and treating neurological conditions
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
WO2016054240A1
(en)
|
2014-09-30 |
2016-04-07 |
Sean Dalziel |
Fixed dose combinations for the treatment of viral diseases
|
EP3207150B1
(de)
|
2014-10-14 |
2021-04-28 |
Research Development Foundation |
Verfahren zur erzeugung von manipulierten enzymen
|
EP3212001A4
(de)
|
2014-10-31 |
2018-04-25 |
Whole Biome Inc. |
Verfahren und zusammensetzungen im zusammenhang mit mikrobieller behandlung und diagnose von störungen
|
JP6758314B2
(ja)
|
2015-03-19 |
2020-09-23 |
サギメット バイオサイエンシーズ インコーポレイテッド |
脂質合成の複素環式調節因子
|
US11433146B2
(en)
|
2015-06-12 |
2022-09-06 |
Vaxart, Inc. |
Formulations for small intestinal delivery of RSV and norovirus antigens
|
BR112018002150A2
(pt)
|
2015-08-03 |
2018-09-18 |
Bioverativ Therapeutics Inc |
proteínas de fusão do fator ix e métodos de fabricação e uso das mesmas
|
EP3352760A4
(de)
|
2015-09-21 |
2019-03-06 |
Aptevo Research and Development LLC |
Cd3-bindende polypeptide
|
EP3383418B1
(de)
|
2015-12-04 |
2021-10-20 |
Board of Regents, The University of Texas System |
Slc45a2-peptide für immuntherapie
|
MA43532A
(fr)
|
2015-12-30 |
2018-11-07 |
Adamas Pharmaceuticals Inc |
Méthodes et compositions destinés au traitement de troubles liés à des crises épileptiques
|
JP2019527065A
(ja)
|
2016-05-04 |
2019-09-26 |
アビリタ バイオ,インク. |
複数膜貫通型タンパク質を調製する方法とプラットフォーム
|
MA53353A
(fr)
|
2016-05-16 |
2021-06-09 |
Intarcia Therapeutics Inc |
Polypeptides sélectifs pour le récepteur du glucagon et méthodes pour leur utilisation
|
JP7195147B2
(ja)
|
2016-05-16 |
2022-12-23 |
アクセス ツー アドバンスト ヘルス インスティチュート |
Peg化リポソームおよび使用方法
|
KR102392974B1
(ko)
|
2016-05-16 |
2022-05-02 |
인펙셔스 디지즈 리서치 인스티튜트 (아이디알아이) |
Tlr 작용제를 함유하는 제제 및 사용 방법
|
AU2017273650B2
(en)
|
2016-06-01 |
2022-08-18 |
Access To Advanced Health Institute |
Nanoalum particles containing a sizing agent
|
US11725232B2
(en)
|
2016-10-31 |
2023-08-15 |
The Hong Kong University Of Science And Technology |
Compositions, methods and kits for detection of genetic variants for alzheimer's disease
|
EP3565580B1
(de)
|
2017-01-03 |
2024-03-06 |
i2o Therapeutics, Inc. |
Kontinuierlicher verabreichung von exenatid und co-verabreichung von acetaminophen, ethinylestradiol oder levonorgestrel
|
US10240205B2
(en)
|
2017-02-03 |
2019-03-26 |
Population Bio, Inc. |
Methods for assessing risk of developing a viral disease using a genetic test
|
WO2018158311A1
(en)
|
2017-02-28 |
2018-09-07 |
University College Cork - National University Of Ireland, Cork |
An intravascular cell therapy device
|
WO2018200885A1
(en)
|
2017-04-26 |
2018-11-01 |
Neurocentria, Inc. |
Magnesium compositions and methods of use
|
US20200115324A1
(en)
|
2017-06-11 |
2020-04-16 |
Molecular Express, Inc. |
Methods and compositions for substance use disorder vaccine formulations and uses thereof
|
CN111315362A
(zh)
|
2017-06-15 |
2020-06-19 |
传染病研究所 |
纳米结构脂质载剂和稳定乳剂以及其用途
|
GB201710973D0
(en)
|
2017-07-07 |
2017-08-23 |
Avacta Life Sciences Ltd |
Scaffold proteins
|
EP3675882A4
(de)
|
2017-08-30 |
2021-07-28 |
Pendulum Therapeutics, Inc. |
Verfahren und zusammensetzungen zur behandlung von erkrankungen im zusammenhang mit mikrobiomen
|
CN110123789A
(zh)
*
|
2018-02-02 |
2019-08-16 |
山东墨海生物科技有限公司 |
一种载利培酮的plga微球混合物及其制备方法
|
WO2019156565A1
(en)
|
2018-02-12 |
2019-08-15 |
Fast Forward Pharmaceuticals B.V. |
Improved antagonistic anti-human cd40 monoclonal antibodies
|
SG11202012044QA
(en)
|
2018-06-29 |
2021-01-28 |
Wuhan Neurophth Biological Tech Limited Company |
Compositions and methods for treating leber's hereditary optic neuropathy
|
EP4177356A1
(de)
|
2018-08-08 |
2023-05-10 |
PML Screening, LLC |
Verfahren zur beurteilung des risikos der entwicklung einer viruserkrankung unter verwendung eines genetischen tests
|
CN112584874A
(zh)
|
2018-08-20 |
2021-03-30 |
武汉纽福斯生物科技有限公司 |
用于治疗莱伯氏遗传性视神经病变的组合物和方法
|
CN111315407B
(zh)
|
2018-09-11 |
2023-05-02 |
上海市公共卫生临床中心 |
一种广谱抗流感疫苗免疫原及其应用
|
WO2020067887A1
(en)
|
2018-09-24 |
2020-04-02 |
Erasmus University Medical Center Rotterdam |
Specific inhibition of janus kinase 3 (jak3) for modulating anti-tumor immune responses
|
WO2020102454A1
(en)
|
2018-11-13 |
2020-05-22 |
Regents Of The University Of Minnesota |
Cd40 targeted peptides and uses thereof
|
EP4013788A1
(de)
|
2019-08-12 |
2022-06-22 |
Purinomia Biotech, Inc. |
Verfahren und zusammensetzungen zur förderung und verstärkung von t-zell-vermittelten immunantworten durch adcc-targeting von cd39-exprimierenden zellen
|
WO2021074695A1
(en)
|
2019-10-16 |
2021-04-22 |
Avacta Life Sciences Limited |
PD-L1 INHIBITOR - TGFβ INHIBITOR BISPECIFIC DRUG MOIETIES.
|
CN113025633A
(zh)
|
2019-12-09 |
2021-06-25 |
武汉纽福斯生物科技有限公司 |
编码人nadh脱氢酶亚单位1蛋白的核酸及其应用
|
AU2021275239A1
(en)
|
2020-05-21 |
2022-12-15 |
Board Of Regents, The University Of Texas System |
T cell receptors with VGLL1 specificity and uses thereof
|
GB202101299D0
(en)
|
2020-06-09 |
2021-03-17 |
Avacta Life Sciences Ltd |
Diagnostic polypetides and methods
|
US20230338501A1
(en)
|
2020-09-04 |
2023-10-26 |
Access To Advanced Health Institute |
Live-attenuated rna hybrid vaccine technology
|
AU2021335334A1
(en)
|
2020-09-04 |
2023-04-20 |
Access To Advanced Health Institute |
Genetically-adjuvanted rna vaccines
|
US20230310323A1
(en)
|
2020-09-04 |
2023-10-05 |
Access To Advanced Health Institute |
Co-lyophilized rna and nanostructured lipid carrier
|
WO2022234003A1
(en)
|
2021-05-07 |
2022-11-10 |
Avacta Life Sciences Limited |
Cd33 binding polypeptides with stefin a protein
|
CN115927472A
(zh)
|
2021-07-05 |
2023-04-07 |
武汉纽福斯生物科技有限公司 |
一种抗vegf抗体体内表达系统的构建和应用
|
WO2023011632A1
(zh)
|
2021-08-06 |
2023-02-09 |
武汉纽福斯生物科技有限公司 |
用于治疗由于nd4突变造成的莱伯氏遗传性视神经病变的组合物和方法
|
WO2023057567A1
(en)
|
2021-10-07 |
2023-04-13 |
Avacta Life Sciences Limited |
Pd-l1 binding affimers
|
WO2023057946A1
(en)
|
2021-10-07 |
2023-04-13 |
Avacta Life Sciences Limited |
Serum half-life extended pd-l1 binding polypeptides
|
WO2023218243A1
(en)
|
2022-05-12 |
2023-11-16 |
Avacta Life Sciences Limited |
Lag-3/pd-l1 binding fusion proteins
|
WO2024052882A1
(en)
|
2022-09-09 |
2024-03-14 |
Access To Advanced Health Institute |
Immunogenic vaccine composition incorporating a saponin
|